Aspen Pharmacare Financials
APN Stock | 16,731 276.00 1.62% |
Aspen |
Understanding current and past Aspen Pharmacare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aspen Pharmacare's financial statements are interrelated, with each one affecting the others. For example, an increase in Aspen Pharmacare's assets may result in an increase in income on the income statement.
Please note, the presentation of Aspen Pharmacare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aspen Pharmacare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Aspen Pharmacare's management manipulating its earnings.
Foreign Associate | USA |
Instrument | South Africa Stock View All |
Exchange | Johannesburg Exchange |
ISIN | ZAE000066692 |
Business Address | Aspen Place, Durban, |
Sector | Healthcare |
Industry | Drug Manufacturers-Specialty & Generic |
Benchmark | Dow Jones Industrial |
Website | www.aspenpharma.com |
Phone | 27 31 580 8600 |
You should never invest in Aspen Pharmacare without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Aspen Stock, because this is throwing your money away. Analyzing the key information contained in Aspen Pharmacare's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Aspen Pharmacare Key Financial Ratios
There are many critical financial ratios that Aspen Pharmacare's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Aspen Pharmacare Holdings reports annually and quarterly.Return On Equity | 0.095 | |||
Return On Asset | 0.0499 | |||
Target Price | 175.61 | |||
Beta | 0.62 | |||
Last Dividend Paid | 3.26 |
Aspen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aspen Pharmacare's current stock value. Our valuation model uses many indicators to compare Aspen Pharmacare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aspen Pharmacare competition to find correlations between indicators driving Aspen Pharmacare's intrinsic value. More Info.Aspen Pharmacare Holdings is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Aspen Pharmacare Holdings is roughly 1.90 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aspen Pharmacare's earnings, one of the primary drivers of an investment's value.Aspen Pharmacare Holdings Systematic Risk
Aspen Pharmacare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aspen Pharmacare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Aspen Pharmacare Holdings correlated with the market. If Beta is less than 0 Aspen Pharmacare generally moves in the opposite direction as compared to the market. If Aspen Pharmacare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aspen Pharmacare Holdings is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aspen Pharmacare is generally in the same direction as the market. If Beta > 1 Aspen Pharmacare moves generally in the same direction as, but more than the movement of the benchmark.
Aspen Pharmacare November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Aspen Pharmacare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aspen Pharmacare Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aspen Pharmacare Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Aspen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aspen Pharmacare's daily price indicators and compare them against related drivers.
Information Ratio | (0.31) | |||
Maximum Drawdown | 14.9 | |||
Value At Risk | (2.42) | |||
Potential Upside | 1.49 |
Complementary Tools for Aspen Stock analysis
When running Aspen Pharmacare's price analysis, check to measure Aspen Pharmacare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspen Pharmacare is operating at the current time. Most of Aspen Pharmacare's value examination focuses on studying past and present price action to predict the probability of Aspen Pharmacare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspen Pharmacare's price. Additionally, you may evaluate how the addition of Aspen Pharmacare to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |